Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature

• DOI: 10.1016/j.mmcr.2017.02.002
• Publication Date: 2017-02-23T00:01:02Z
• Authors: Serkan Atıcı; Ahmet Soysal; Kıvılcım Karadeni...; Şerife Yılmaz; Burak Aksu; Gürsu Kıyan; Mustafa Bakır
• Keywords: 0301 basic medicine; Medicine (General); 0303 health sciences; QH301-705.5; Case Report; Saccharomyces cerevisiae; 3. Good health; Saccharomyces boulardii; 03 medical and health sciences; Probiotic treatment; R5-920; Intensive care unit; Biology (General); Fungemia

Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing S. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We want to emphasize that physicians should be careful about probiotic usage in critically ill patients.